Prosecution Insights
Last updated: May 29, 2026

Riverside Law LLP

158 pending office actions • 60 clients • 145 examiners • 84 art units • 0 of 158 (0%) have an AI response strategy ready • 124 patents granted in the last 365 days

Portfolio Summary

158
Total Pending OAs
102
Non-Final OAs
54
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 157 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

87
Overdue
4
Due this week
44
Due this month
13
Due in next 60 days
9
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 157 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (87)Due ≤ 7 days (4)Due ≤ 30 days (44)Due ≤ 60 days (13)Due later (9)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (1%)
105
Medium (66%)
23
Easy (15%)
28
Unknown (18%)

Rejection Statute Mix

BucketCases
§101 only2 (1%)
§103 only92 (58%)
§102 only13 (8%)
§112 only22 (14%)
Double-patenting only1 (1%)
No statute on record28 (18%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

108
Life Sciences
68% of docket
1
Information Tech
1% of docket
2
Communications
1% of docket
3
Semiconductors
2% of docket
43
Mechanical / Eng
27% of docket
1
Business / Other
1% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,580 h
Manual time on pending OAs
316 h
Time saved (low, 20%)
553 h
Time saved (mid, 35%)
13.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SUL, DOUGLAS YOUNG 2 54.5% +57.1%
HAMMOND, ELLEN CHRISTINA 2 78.0% +11.8%
BOESEN, AGNIESZKA 2 68.1% +21.9%
PARKIN, JEFFREY S 2 63.5% +21.4%
ARNOLD, ERNST V 2 48.0% +12.9%
GILL, RACHEL B 2 65.6% +27.7%
SCHUBERG, LAURA J 2 23.7% +36.7%
VOORHEES, CATHERINE M 2 83.3% +14.4%
SALVOZA, M FRANCO G 2 69.0% +29.4%
DABKOWSKI, ERINNE R 2 55.8% +69.0%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18006321 LIQUID CRYSTAL SCAFFOLDS AND USE THEREOF SCHUBERG, LAURA J 37d overdue
18365369 Method for Determining Prognosis of Cancer AEDER, SEAN E 3d overdue
18194781 METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE SCHUBERG, LAURA J 13d
18291641 Instruction Parsing Method and Apparatus, and Electronic Device CHEN, QING 62d

Interview Candidates (20)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18477785 COMBINATION OF NOVEL VACCINES AGAINST ZIKA VIRUS AND DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ZIKA VIRUS PARKIN, JEFFREY S 155d overdue
18263420 METHOD FOR PREPARING PROTEIN MICROBEADS FOR IMPROVING STABILITY OF PROTEIN PREPARATION ARNOLD, ERNST V 139d overdue
17995194 FACTOR B INHIBITORS AND USES THEREOF DABKOWSKI, ERINNE R 93d overdue
18526819 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HIV BOESEN, AGNIESZKA 78d overdue
17518243 DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENT VOORHEES, CATHERINE M 71d overdue
18437843 FLEXIBLE IMPLANTS AND METHODS OF ENHANCED BONE FIXATION HAMMOND, ELLEN CHRISTINA 56d overdue
18006321 LIQUID CRYSTAL SCAFFOLDS AND USE THEREOF SCHUBERG, LAURA J 37d overdue
17592169 BIOMIMETIC TISSUE AND METHOD OF USE THEREOF ARNOLD, ERNST V 36d overdue

Client Portfolio (60 clients)

Top Art Units

Art UnitApps
16719
37917
16726
37854
37924
37714
16454
16314
37753
16333

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19067406 Doped Organic Semiconductors and Methods of Making the Same New York University NGUYEN, HAIDUNG D 1761 §102 Non-Final OA 45d overdue Pending Feb 28, 2025
19028830 Product, system and method of cell cultivation Btl Healthcare Technologies A.S. LOPEZLIRA, ASHLEY NICOLE 1799 §112 Non-Final OA 76d Pending Jan 17, 2025
19029092 Rapid Cycling Compression Device for the Prevention of Thrombosis Osciflex LLC SUL, DOUGLAS YOUNG 3785 §103 Non-Final OA 27d Pending Jan 17, 2025
18985963 APPARATUS, SYSTEM AND METHOD FOR AN ADDITIVE MANUFACTURING PRINT HEAD 3D Print Innovations, LLC MCKANE, ELIZABETH L 3991 §103 Non-Final OA 48d Pending Dec 18, 2024
18939015 SYSTEM AND METHOD FOR TETHERED UNMANNED AERIAL VEHICLE TAKEOFF, LANDING, AND STORAGE Dragonfly Pictures, Inc. BAAJOUR, SHAHIRA 3666 §103 Non-Final OA 41d Pending Nov 06, 2024
18904575 Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells The Trustees of the University of Pennsylvania WESTERBERG, NISSA M 1618 Other Non-Final OA 18d overdue Pending Oct 02, 2024
18814421 SWITCHING OF PERPENDICULARLY MAGNETIZED NANOMAGNETS WITH SPIN-ORBIT TORQUES IN THE ABSENCE OF EXTERNAL MAGNETIC FIELDS UNIVERSITY OF ROCHESTER NGUYEN, VAN THU T 2824 §103 Non-Final OA 15d Pending Aug 23, 2024
18753142 Ceramic-Polymer Composites and Methods of Making the Same Temple University Of The Commonwealth System Of Higher Education ZHANG, HAI Y 1717 §103 Non-Final OA 46d Pending Jun 25, 2024
18745131 SYSTEM AND METHOD FOR BREAST CANCER DETECTION USING CO-LOCALIZED ULTRASOUND-MAMMOGRAPHY Thomas Jefferson University FERNANDEZ, KATHERINE L 3798 §112 Non-Final OA 14d Pending Jun 17, 2024
18731896 PET FOOD, METHODS AND DEVICES FOR PRODUCING PET FOOD Btl Healthcare Technologies A.S. TURNER, FELICIA C 1793 §103 Final Rejection 17d overdue Pending Jun 03, 2024
18675291 LIGHT SOURCES THAT INCREASE OBJECT CHROMA WHEN DIMMED The Penn State Research Foundation CHAI, RAYMOND REI-YANG 2844 §103 Non-Final OA 28d overdue Pending May 28, 2024
18673924 SYSTEM AND METHOD OF POSE DETECTION Accompaneed LLC FUJITA, KATRINA R 2672 §112 Non-Final OA 20d Pending May 24, 2024
18660594 MACHINE LEARNING SYSTEM AND METHODS FOR INCREASING APPOINTMENT COMPLIANCE Yale University GILLIGAN, CHRISTOPHER L 3683 §103 Final Rejection 23d Pending May 10, 2024
18656948 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS Inovio Pharmaceuticals, Inc. BLUMEL, BENJAMIN P 1671 Other Final Rejection 80d overdue Pending May 07, 2024
18656545 SOFT TISSUE RETRACTORS Wrmdsv Iv, LLC NELSON, CHRISTINE L 3772 §103 Non-Final OA 4d overdue Pending May 06, 2024
18646987 DRILL GUIDE FOR IMPLANTABLE HEARING DEVICES UNIVERSITY OF ROCHESTER KU, SI MING 3775 §102 Final Rejection 76d Pending Apr 26, 2024
18703591 COMPOSITION FOR AMELIORATING HAIR LOSS COMPRISING BOTULINUM-DERIVED PEPTIDE BPMED CO., LTD. IANNUZO, NATALIE NMN 1653 §103 Non-Final OA 72d Pending Apr 22, 2024
18702407 CONCENTRIC TUBE DRILLING ROBOT DEVICE, SYSTEM AND METHOD BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM YANG, ANDREW 3775 §103 Non-Final OA 9d overdue Pending Apr 18, 2024
18701320 METHODS AND SYSTEMS FOR PROCESSING AND FORMULATING PLANT MATERIAL Flowerpod, LLC PACKARD, BENJAMIN J 1612 §103 Non-Final OA 42d Pending Apr 15, 2024
18633750 SYSTEM AND METHOD FOR GENERATING VIDEOS DEPICTING VIRTUAL CHARACTERS UNIVERSITY OF ROCHESTER LE, MICHAEL 2614 §103 Non-Final OA 19d overdue Pending Apr 12, 2024
18609070 Use of Short Chain Fatty Acids in Cancer Prevention Temple University-Of The Commonwealth System Of Higher Education PYLA, EVELYN Y 1633 §103 Non-Final OA 2d overdue Pending Mar 19, 2024
18690480 SYSTEM AND METHOD FOR STEREOSCOPIC IMAGE GENERATION New York University BRUTUS, JOEL F 3797 §103 Non-Final OA 8d overdue Pending Mar 08, 2024
18590310 SYSTEM AND METHOD FOR UNMANNED AERIAL SIGNAL RELAY Dragonfly Pictures, Inc. LEITE, PAULO ROBERTO GONZ 3663 §103 Non-Final OA 9d Pending Feb 28, 2024
18588643 MAGE-A VACCINES AND METHODS OF TREATMENT USING THE SAME The Wistar Institute EDGINGTONGIORDANO, FRANCESCA 1643 Other Non-Final OA 37d overdue Pending Feb 27, 2024
18439561 SYSTEMS AND METHODS FOR TISSUE TREATMENT Btl Healthcare Technologies A.S. TEIXEIRA MOFFAT, JONATHAN CHARLES 3792 §102 Non-Final OA 2d overdue Pending Feb 12, 2024
18437843 FLEXIBLE IMPLANTS AND METHODS OF ENHANCED BONE FIXATION BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM HAMMOND, ELLEN CHRISTINA 3773 §103 Non-Final OA 56d overdue Pending Feb 09, 2024
18291641 Instruction Parsing Method and Apparatus, and Electronic Device Peking University Chongqing Research Institute Of Big Data CHEN, QING 2191 §101 Final Rejection 62d Pending Jan 24, 2024
18407958 Extreme Polyvalency Induces Potent Cross-Clade Cellular and Humoral Responses in Rabbits and Non-human Primates The Wistar Institute LI, BAO Q 1671 §103 Non-Final OA 40d Pending Jan 09, 2024
18577390 FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS 484 Science Corp. HOLLOMAN, NANNETTE 1612 §103 Non-Final OA 40d Pending Jan 08, 2024
18405123 Labral Anchor System and Method Aevumed, Inc. DAVID, SHAUN L 3771 §103 Final Rejection 23d overdue Pending Jan 05, 2024
18539995 Persistent Luminescent Nanoparticle and Articles Comprising the Same Thomas Jefferson University KOSLOW, CAROL M 1734 §103 Non-Final OA 31d overdue Pending Dec 14, 2023
18569842 MORPHABLE BONE FIXATION DEVICE, SYSTEM AND METHOD BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM JOHANAS, JACQUELINE T 3773 §103 Non-Final OA 22d Pending Dec 13, 2023
18526819 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HIV Inovio Pharmaceuticals, Inc. BOESEN, AGNIESZKA 1672 Other Non-Final OA 78d overdue Pending Dec 01, 2023
18566362 DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM WRUBLESKI, MATTHEW JAMES 3781 §103 Non-Final OA 23d Pending Dec 01, 2023
18517137 PEER-BASED AUDITING SYSTEM AND METHOD Novadata Solutions LLC CHAMPAGNE, LUNA 3627 §103 Final Rejection 16d Pending Nov 22, 2023
18512727 3D PRINTED SCAFFOLDS FOR USE IN TISSUE REPAIR Aevumed, Inc. STRANSKY, KATRINA MARIE 3700 §103 Non-Final OA 2d overdue Pending Nov 17, 2023
18503487 Vaccines For Human Papilloma Virus And Methods For Using The Same Inovio Pharmaceuticals, Inc. ZOU, NIANXIANG 1671 Other Final Rejection 138d overdue Pending Nov 07, 2023
18558049 SYSTEM AND METHOD FOR CONDITIONING AIR Thomas Jefferson University MOORE, DEVON TYLEN 3763 §103 Non-Final OA 124d overdue Pending Oct 30, 2023
18556746 COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY MITOCHONDRIAL DYSFUNCTION, CONTAINING ISOQUINOLINE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT Altmedicalco., Ltd. HABTE, KAHSAY 1624 §112 Non-Final OA 13d Pending Oct 23, 2023
18556414 GLYCAN MODIFIED SPIKE RECEPTOR BINDING DOMAIN NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE The Wistar Institute BOESEN, AGNIESZKA 1672 DP Non-Final OA 84d Pending Oct 20, 2023
18555112 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER Yale University COUGHLIN, MATTHEW P 1626 §102 Non-Final OA 13d Pending Oct 12, 2023
18479174 APPARATUS, SYSTEM AND METHOD FOR PLUG CLEARING IN AN ADDITIVE MANUFACTURING PRINT HEAD 3D Print Innovations, LLC WOO, JONATHAN BRIAN 1754 §103 Final Rejection 14d Pending Oct 02, 2023
18477785 COMBINATION OF NOVEL VACCINES AGAINST ZIKA VIRUS AND DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ZIKA VIRUS The Wistar Institute PARKIN, JEFFREY S 1671 §112 Final Rejection 155d overdue Pending Sep 29, 2023
18472378 SYSTEM FOR GAIT TRAINING BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM ATKINSON, GARRETT K 3784 §102 Non-Final OA 36d overdue Pending Sep 22, 2023
18458214 Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders UNIVERSITAT DE BARCELONA ALLEN, MARIANNE P 1647 §112 Non-Final OA 104d overdue Pending Aug 30, 2023
18450169 APPARATUS, SYSTEM AND METHOD FOR ULTRASONIC-BASED ADDITIVE MANUFACTURING 3D Print Innovations LLC HEMINGWAY, TIMOTHY G 1754 §103 Final Rejection 4d overdue Pending Aug 15, 2023
18449091 DEVICE, SYSTEM AND METHOD FOR MONITORING NEUROLOGICAL FUNCTIONAL STATUS Musc Foundation For Research Development CERIONI, DANIEL LEE 3791 §103 Final Rejection 56d overdue Pending Aug 14, 2023
18264701 RENAL NEUROMODULATION The Regents of the University of California TEJANI, ANKIT D 3796 Other Final Rejection 19d overdue Pending Aug 08, 2023
18365369 Method for Determining Prognosis of Cancer Queen Mary University Of London AEDER, SEAN E 1642 §101 Non-Final OA 3d overdue Pending Aug 04, 2023
18264125 FLEXIBLE IMPLANTS AND METHODS OF ENHANCED BONE FIXATION BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM HAMMOND, ELLEN CHRISTINA 3773 §103 Final Rejection 16d Pending Aug 03, 2023
18263420 METHOD FOR PREPARING PROTEIN MICROBEADS FOR IMPROVING STABILITY OF PROTEIN PREPARATION Dongguk University Industry-Academic Cooperation Foundation ARNOLD, ERNST V 1613 §103 Non-Final OA 139d overdue Pending Jul 28, 2023
18359521 EXOSUIT DEVICE AND METHOD FOR EXOSUIT MODELING AND DESIGN BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM MILLER, DANIEL A 3786 §103 Non-Final OA 5d Pending Jul 26, 2023
18262127 Amino Acid Dehydrogenase Mutant and use thereof Asymchem Life Science (Tianjin) Co., Ltd. STAPON, ANTHONY SCOTT 1656 Other Non-Final OA 4d overdue Pending Jul 19, 2023
18261568 Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines UNIVERSITY OF ROCHESTER GRASER, JENNIFER E 1645 §103 Non-Final OA 5d Pending Jul 14, 2023
18342930 LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS The Catholic University Of Korea Industry-Academic Cooperation Foundation CANDELARIA, JULIANA IRENE 1634 §112 Non-Final OA 14d Pending Jun 28, 2023
18259106 HUMANIZED ANTI-C5 ANTIBODIES AND FACTOR H FUSION PROTEINS AND USES THEREOF Kira Pharmaceuticals (Us) LLC NICKOL, GARY B 1643 §112 Non-Final OA 42d overdue Pending Jun 23, 2023
18256752 SUSTAINED RELEASE FORMULATIONS OF CRYSTALLINE DRUGS Queen Mary University Of London KASSA, TIGABU 1619 §103 Non-Final OA 8d overdue Pending Jun 09, 2023
18329957 METHODS OF TREATING DISEASES AND DISORDERS ASSOCIATED WITH CALCIUM ION SIGNALING Temple University-Of The Commonwealth System Of Higher Education SZNAIDMAN, MARCOS L 1628 §103 Non-Final OA 9d overdue Pending Jun 06, 2023
18324228 NEUROMODULATION TO ENHANCE PHYSICAL ACTIVITY BEHAVIOR Arizona Board of Regents ALTER MORSCHAUSER, ALYSSA MARGO 3796 §103 Final Rejection 10d overdue Pending May 26, 2023
18254052 COMPOSITION FOR PREPARING DECELLULARIZED SCAFFOLD, COMPRISING GRAPHENE NANOSTRUCTURE BIOGO CO., LTD. WOZNICKI, JACQUELINE 3774 §103 Final Rejection 16d Pending May 23, 2023
18318957 MICROFLUIDIC FLOW CONTROL New York University RAEVIS, ROBERT R 2855 §103 Final Rejection 44d overdue Pending May 17, 2023
18252440 FLOW REGULATION MECHANISM FOR COMPARTMENTALIZED LUNG VENTILATION The Regents of the University of California RUSSELL, SYDNEY REYES 3785 §103 Non-Final OA 3d overdue Pending May 10, 2023
18314211 NEURAL MODULATION OF AUTONOMIC NERVOUS SYSTEM TO ALTER MEMORY AND PLASTICITY OF THE AUTONOMIC NETWORK The Regents of the University of California DIETRICH, JOSEPH M 3796 §102 Non-Final OA 72d overdue Pending May 09, 2023
18251620 DNA ENCODED NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE The Wistar Institute GILL, RACHEL B 1671 Other Non-Final OA 11d overdue Pending May 03, 2023
18034693 DEVICES AND METHODS FOR MONITORING CELLS, TISSUES, OR ORGANS-ON-A-CHIP UNIVERSITY OF ROCHESTER GERHARD, ALISON CLAIRE 1797 §103 Non-Final OA 19d Pending Apr 29, 2023
18250629 COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROMUSCULAR DISEASES COMPRISING CDO PROTEIN OR GENE ENCODING SAME Animuscure Inc. VYAS, KEYUR ANILKUMAR 1637 §103 Non-Final OA 6d Pending Apr 26, 2023
18299272 Rapid Cycling Compression Device for the Prevention of Thrombosis Osciflex LLC SUL, DOUGLAS YOUNG 3785 §103 Non-Final OA 34d Pending Apr 12, 2023
18248648 COMPOSITION FOR PREVENTING OR TREATING NEUROMUSCULAR DISEASE, COMPRISING PRMT1 PROTEIN OR GENE ENCODING SAME Animuscure Inc. DAVIS, RUTH A 1699 §103 Final Rejection 70d Pending Apr 11, 2023
18297160 NASAL MOLDING DEVICE New York University JAMIALAHMADI, MAJID 3771 §103 Final Rejection 26d overdue Pending Apr 07, 2023
18248166 METHOD FOR DETERMINING WHETHER OR NOT VIRUS-NEUTRALIZING ANTIBODIES ARE PRESENT AND IN VITRO METHOD FOR SCREENING COMPOUNDS FOR THEIR ABILITY TO NEUTRALIZE A VIRUS Eximmium Biotechnologies GmbH GRIZER, CASSANDRA SENN 1672 §103 Non-Final OA 84d overdue Pending Apr 06, 2023
18194781 METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE Seoul National University Hospital SCHUBERG, LAURA J 1631 §103 Non-Final OA 13d Pending Apr 03, 2023
18247519 Advanced Cell-Permeable Peptide Carriers Musc Foundation For Research Development PAULUS, ERIN VIRGINIA 1631 §103 Non-Final OA 29d overdue Pending Mar 31, 2023
18247155 JOINT DISTRACTION DEVICE New York University HANNA, SAMUEL SALEEB 3775 §103 Final Rejection 10d overdue Pending Mar 29, 2023
18191314 MONITORING NEUROLOGICAL FUNCTIONAL STATUS Musc Foundation For Research Development NGUYEN, HUONG Q 3791 §103 Final Rejection 29d overdue Pending Mar 28, 2023
18184813 DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENT Btl Healthcare Technologies A.S. VOORHEES, CATHERINE M 3792 Other Final Rejection 27d Pending Mar 16, 2023
18042796 INTRADERMAL MERS-CoV VACCINE The Wistar Institute GILL, RACHEL B 1671 §102 Final Rejection 12d Pending Feb 24, 2023
18040515 METHODS AND COMPOSITIONS FOR TREATING CYTOKINE RELEASE SYNDROME Temple University-Of The Commonwealth System Of Higher Education PIHONAK, SARAH 1627 §103 Non-Final OA 45d overdue Pending Feb 03, 2023
18007317 EXPRESSION HOST BIOTALYS NV LYONS, MARY M 1645 §102 Non-Final OA 15d overdue Pending Jan 30, 2023
18160535 Compositions and Methods for Tendon Regeneration UNIVERSITY OF ROCHESTER BUTTICE, AUDREY L 1647 Other Non-Final OA Pending Jan 27, 2023
18158768 Biomarkers for identifying e-cigarette, or vaping, product use-associated lung injury UNIVERSITY OF ROCHESTER COUNTS, GARY W 1678 §103 Non-Final OA 9d overdue Pending Jan 24, 2023
18006321 LIQUID CRYSTAL SCAFFOLDS AND USE THEREOF Amir Nasajpour SCHUBERG, LAURA J 1631 Other Non-Final OA 37d overdue Pending Jan 20, 2023
18006339 IMPLANTS AND METHOD FOR FORMING AN IMPLANT Bellaseno GmbH GHERBI, SUZETTE JAIME J 3774 §103 Non-Final OA 61d Pending Jan 20, 2023
18005444 COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC Yale University DEVI, SARVAMANGALA 1645 Non-Final OA 4d overdue Pending Jan 13, 2023
18005311 Targeted RNA cleavage with dCas13-RNase Fusion Proteins UNIVERSITY OF ROCHESTER RYAN, DOUGLAS CHARLES 1635 §112 Non-Final OA 27d Pending Jan 12, 2023
18002125 Containment, Treatment, and Removal of Aerosolized Viral Contamination Aeragen, Inc. LANNU, JOSHUA DARYL DEANON 3791 §103 Non-Final OA 20d Pending Dec 16, 2022
18065736 MEASURING FREQUENCY OF PATHOGEN-SPECIFIC T CELLS IN PERIPHERAL BLOOD Thomas Jefferson University GAO, ASHLEY HARTMAN 1678 Other Non-Final OA 22d Pending Dec 14, 2022
18064482 LARGE AND SMALL T ANTIGENS OF MERKEL CELL POLYOMAVIRUS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME The Wistar Institute FOLEY, SHANON A 1671 Other Non-Final OA 138d overdue Pending Dec 12, 2022
18001116 CORONAVIRUS DISEASE 2019 (COVID-19) COMBINATION VACCINE The Wistar Institute STUART, CAREY ALEXANDER MC 1671 Other Non-Final OA 79d overdue Pending Dec 08, 2022
18000531 Monoclonal Antibody Against Human Siglec-9 and Use For Immunotherapy David Weiner JUEDES, AMY E 1644 Other Final Rejection 88d overdue Pending Dec 02, 2022
18059476 Gradient Structures Interfacing Microfluidics and Nanofluidics, Methods for Fabrication and Uses Thereof Princeton University SIEFKE, SAMUEL P 1758 §112 Non-Final OA 31d overdue Pending Nov 29, 2022
18000011 NONINVASIVE CRANIAL NERVE THERAPY Musc Foundation For Research Development WEBSTER, KARMEL JOHANNA 3792 §103 Final Rejection 52d overdue Pending Nov 28, 2022
18058366 MINIMALLY INVASIVE ANCHOR DRILL SYSTEMS Aevumed, Inc. DORNBUSCH, DIANNE 3771 §103 Non-Final OA 32d overdue Pending Nov 23, 2022
17998170 Polymer Composites and Methods of Making the Same Temple University-Of The Commonwealth Systemof Higher Education JOHNSON, JENNA LEIGH 1789 §103 Final Rejection 70d overdue Pending Nov 08, 2022
17997963 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HEPATITIS B VIRUS The Wistar Institute XIAO, YAN 1642 §102 Non-Final OA 28d Pending Nov 04, 2022
18046705 JACKFRUIT FLOUR, METHOD OF PREPARATION AND USES THEREOF God's Own Food Solutions Pvt. Ltd. MORENO, LARK JULIA 1793 §103 Non-Final OA 8d Pending Oct 14, 2022
17996119 CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE Thomas Jefferson University SALVOZA, M FRANCO G 1672 Other Non-Final OA 30d overdue Pending Oct 13, 2022
18045575 TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME Inovio Pharmaceuticals, Inc. ALAWADI, SARAH 1619 Other Final Rejection 34d Pending Oct 11, 2022
17995327 ACTIVE SUBSTANCES FOR MEDICAL USE Inflamed Pharma GmbH HSU, GRACE CHING 1627 §112 Final Rejection 73d overdue Pending Oct 03, 2022
17995194 FACTOR B INHIBITORS AND USES THEREOF The Trustees of the University of Pennsylvania DABKOWSKI, ERINNE R 1654 §102 Final Rejection 93d overdue Pending Sep 30, 2022
17907697 Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 The Wistar Institute ROSSI, JULIA ANNE LORRAIN 1615 Non-Final OA 167d overdue Pending Sep 29, 2022
17907121 Targeted Destruction of Viral RNA by CRISPR-Cas13 UNIVERSITY OF ROCHESTER HILL, KEVIN KAI 1638 §103 Non-Final OA 145d overdue Pending Sep 23, 2022
17906792 In vivo targeting of CD4+-T cells for mRNA therapeutics The Trustees of the University of Pennsylvania HUYNH, PHUONG N 1641 §103 Non-Final OA 126d overdue Pending Sep 20, 2022
17906763 COMPOSITION AND KIT FOR REMOVING LIPOPOLYSACCHARIDE Hlb Science Inc. MARTINEZ, TARA L 1654 Other Non-Final OA 13d Pending Sep 20, 2022
17906694 Preparation of Cerium (III) Carbonate Dispersion Rohm And Haas Company QUIST, NICOLE LEE 1738 §103 Final Rejection 23d overdue Pending Sep 19, 2022
17906087 WELL PLATE AND PETRI DISH FLUID EXCHANGE PLUG The Regents of the University of California HYUN, PAUL SANG HWA 1796 §103 Non-Final OA 59d overdue Pending Sep 12, 2022
17941159 HAND-HELD RADAR SYSTEM TO MEASURE INTRAOCULAR PRESSURE AND TO ASSESS EYE DISEASES AND METHOD THEREFOR Natural Eye Care, Inc. KREMER, MATTHEW 3791 §112 Final Rejection 15d Pending Sep 09, 2022
17904994 Method for synthesizing a fluorine-containing chiral amine compound Asymchem Laboratories (Tianjin) Co., Ltd. HUTSON, RICHARD G 1652 §112 Non-Final OA 26d Pending Aug 25, 2022
17817696 METHOD OF DIAGNOSIS, PROGNOSIS, AND TREATMENT OF VITAMIN D DEFICIENCY AND VITAMIN D IMBALANCE AND DISEASES AND DISORDERS ASSOCIATED THEREOF Temple University-Of The Commonwealth System Of Higher Education TURK, NEIL N 1798 §112 Final Rejection 69d Pending Aug 05, 2022
17817125 PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS Musc Foundation For Research Development RAHMAN, MASUDUR 1633 §102 Final Rejection 9d Pending Aug 03, 2022
17813762 CANCER VACCINES AND METHODS OF TREATMENT USING THE SAME Inovio Pharmaceuticals, Inc. SALVOZA, M FRANCO G 1672 Other Non-Final OA 28d Pending Jul 20, 2022
17813395 INTEGRATED CIRCUIT WITH TOPOLOGICAL SEMIMETAL INTERCONNECTS Yale University DUMBRIS, SETH M 1784 §103 Final Rejection 34d Pending Jul 19, 2022
17811403 COMPOSITION FOR INDUCING DIFFERENTIATION INTO INSULIN-PRODUCING CELLS, AND USE THEREOF Seoul National University Hospital TINSLEY, BRENDAN THOMAS 1634 §103 Final Rejection 9d Pending Jul 08, 2022
17845461 COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS Yale University MOLOYE, TITILAYO 1632 §103 Final Rejection 36d overdue Pending Jun 21, 2022
17842225 METHODS FOR TREATING EYE DISEASE The United States Department of Veterans Affairs HILL, KEVIN KAI 1638 §103 Non-Final OA 28d overdue Pending Jun 16, 2022
17785184 UNNATURAL AMINO ACIDS AND USES THEREOF Temple University-Of The Commonwealth System Of Higher Education VAJDA, KRISTIN ANN 1622 §102 Final Rejection 22d Pending Jun 14, 2022
17782338 A T cell-based immunotherapy for central nervous system viral infections and tumors Yale University ALSOMAIRY, SARAH ABDOALATIF 1646 Other Final Rejection 15d Pending Jun 03, 2022
17825979 Processing sequencing data relating to amyotrophic lateral sclerosis Genieus Genomics Pty Ltd. THOMPSON, MILANA KAYE 1687 §103 Non-Final OA 66d overdue Pending May 26, 2022
17748315 ENGINEERED MICROBIAL POPULATION BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM MONTANARI, DAVID A 1632 §103 Non-Final OA 66d overdue Pending May 19, 2022
17736535 Screening and Assessment of Carcinomas New York University HALVORSON, MARK 1646 §112 Final Rejection 30d overdue Pending May 04, 2022
17771320 Vaginal Drug Delivery Device The Regents of the University of California LAZARO, DOMINIC 1611 §103 Non-Final OA 30d overdue Pending Apr 22, 2022
17769686 Bio-Zipper Surgical Closure Device The Regents of the University of California SCHWIKER, KATHERINE H 3771 §103 Non-Final OA 31d overdue Pending Apr 15, 2022
17767857 ONCOLYTIC VIRUS COMPRISING IMMUNOMODULATORY TRANSGENES AND USES THEREOF Arizona Board of Regents YOUTCHOM PENDIE, EMMANUEL LED 1647 Other Final Rejection 21d Pending Apr 08, 2022
17715352 Devices and Systems for Non-Destructive Collection and Monitoring of Biological Volatiles Arizona Board of Regents GZYBOWSKI, MICHAEL STANLEY 1798 §103 Non-Final OA 35d overdue Pending Apr 07, 2022
17705762 DEPOLYMERIZATION AND VALORIZATION OF A BIOPOLYMER New York University CHO, DAVID H 1693 §103 Non-Final OA 9d Pending Mar 28, 2022
17761123 APPARATUS AND METHODS FOR BIODIFFUSION CHAMBER STORAGE Imvax, Inc. ACKUN, JACOB K 3736 §112 Non-Final OA 22d Pending Mar 16, 2022
17642256 NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER INTEGRATING CLINICAL VARIABLES AND GENE EXPRESSION DATA The University of Guildford KENNEDY, SARAH JANE 1682 §103 Final Rejection 100d overdue Pending Mar 11, 2022
17689867 Epigenomic editing and reactivation of targets for the treatment of Fragile X syndrome The Trustees of the University of Pennsylvania ESSEX, LAURA ANN 1675 §103 Non-Final OA 100d overdue Pending Mar 08, 2022
17680716 Photovoltaic Devices and Methods of Making the Same New York University MALLEY JR., DANIEL PATRICK 1726 §103 Final Rejection 42d overdue Pending Feb 25, 2022
17636209 Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders Arizona Board of Regents NGUYEN, JOHN P 1619 §103 Final Rejection 19d overdue Pending Feb 17, 2022
17592169 BIOMIMETIC TISSUE AND METHOD OF USE THEREOF New York University ARNOLD, ERNST V 1613 §103 Non-Final OA 36d overdue Pending Feb 03, 2022
17584125 Use of short chain fatty acids for the treatment and prevention of diseases and disorders Temple University-Of The Commonwealth System Of Higher Education ALLEY, GENEVIEVE S 1617 §103 Final Rejection 77d overdue Pending Jan 25, 2022
17628913 Targeted RNA cleavage with CRISPR-Cas UNIVERSITY OF ROCHESTER SPENCER, ANDREA LYNNE MORRIS 1631 §102 Final Rejection 20d Pending Jan 21, 2022
17627612 SYSTEM AND METHOD FOR MEASURING TISSUE PARAMETERS BY USE OF CAPACITIVE TACTILE SENSOR UE LifeSciences Inc. XU, JUSTIN 3791 §103 Non-Final OA 14d Pending Jan 14, 2022
17541154 NON-INVASIVE PROPRIOCEPTIVE STIMULATION FOR TREATING EPILEPSY The Regents of the University of California MILLER, CHRISTOPHER E 3785 §103 Final Rejection 38d overdue Pending Dec 02, 2021
17534718 NON-CONTACT CELL MANIPULATION SYSTEM, DEVICE AND METHOD New York University In Abu Dhabi Corporation HASSAN, LIBAN M 1799 §112 Final Rejection 69d Pending Nov 24, 2021
17609451 DNA ENCODED IL-36 GAMMA AS AN ADJUVANT The Wistar Institute PARKIN, JEFFREY S 1671 §112 Non-Final OA 13d Pending Nov 08, 2021
17518243 DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENT Btl Healthcare Technologies A.S. VOORHEES, CATHERINE M 3792 Other Non-Final OA 71d overdue Pending Nov 03, 2021
17605695 BI-FUNCTIONAL HUMANIZED ANTI-C5 ANTIBODIES AND FACTOR H FUSION PROTEINS AND USES THEREOF Kira Pharmaceuticals (Us) LLC MELCHIOR, JAMES RYLAND 1644 Other Final Rejection 4d overdue Pending Oct 22, 2021
17602985 ENGINEERING A NATURALLY-DERIVED ADHESIVE AND CONDUCTIVE CARDIO-PATCH The Regents of the University of California HOERNER, PAUL ELLSWORTH 1611 §103 Non-Final OA 19d overdue Pending Oct 11, 2021
17488409 DIGITALLY COACHED SPIROMETRY SYSTEM AND METHOD Monitored Therapeutics Inc. CATINA, MICHAEL ANTHONY 3791 §103 Non-Final OA 66d overdue Pending Sep 29, 2021
17486823 ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL CANCER Roy Duncan JADHAO, SAMADHAN JAISING 1672 §103 Final Rejection 38d overdue Pending Sep 27, 2021
15733794 NONWOVEN HEMP HURD-BASED MATERIALS Thomas Jefferson University SINGH-PANDEY, ARTI R 1759 §103 Non-Final OA 50d overdue Pending Sep 23, 2021
17432658 Methods of modulating immune response Garvan Institute Of Medical Research SULLIVAN, STEPHANIE LAUREN 1635 §103 Non-Final OA 20d Pending Aug 20, 2021
17431813 BEE GUT MICROBIAL FORMULATION FOR USE AS A PROBIOTIC FOR IMPROVED BEE HEALTH AND PATHOGEN RESISTANCE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM EIX, EMILY FAY 1653 §103 Non-Final OA 12d Pending Aug 18, 2021
17426201 METHOD FOR DETECTING A SPECIFIC SPLICE EVENT OF A GENE OF INTEREST Klinikum Rechts Der Isar Der Technischen Universität München PERSONS, JENNA L 1637 §112 Non-Final OA 11d overdue Pending Jul 28, 2021
17425384 NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER UEA Enterprises Limited CLOW, LORI A 1687 §103 Non-Final OA 66d overdue Pending Jul 23, 2021
17371613 GRAPHITIC CARBON NITRIDE MATERIALS AND METHODS OF MAKING AND USE THEREOF New York University ALEJANDRO, RAYMOND 1752 §103 Non-Final OA 28d Pending Jul 09, 2021
17317057 DETECTION OF AUTOREACTIVE FECAL IMMUNOGLOBULIN A (IGA) FOR DIAGNOSIS OF LUPUS Musc Foundation For Research Development BALLARD, KIMBERLY 1675 §103 Final Rejection 34d Pending May 11, 2021
17290797 METHODS AND COMPOSITIONS FOR TREATING HEPATOCELLULAR CARCINOMA USING ANTISENSE Thomas Jefferson University VAN DRUFF, SYDNEY 1643 Other Non-Final OA 6d Pending May 03, 2021
17289882 Quantitative Algorithm for Endometriosis Yale University LIU, GUOZHEN 1686 §103 Non-Final OA 13d Pending Apr 29, 2021
17287184 Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein UNIVERSITY OF ROCHESTER HASAN, KHALEDA B 1636 Other Non-Final OA 42d Pending Apr 21, 2021
17283315 Selective Binding and Aggregation of Human Keratin in the Skin Barrier Using Human Filaggrin Subdomains SD67 and SD150 Yale University DABKOWSKI, ERINNE R 1654 §112 Final Rejection 57d Pending Apr 07, 2021
17279777 TREATMENT OF DEMENTIA-ASSOCIATED TAUOPATHIES Deutsches Zentrum Fur Neurodegenerative Erkrankungen E.V. (Dzne) PALLAY, MICHAEL B 1617 §103 Non-Final OA 85d overdue Pending Mar 25, 2021
16973603 COMPOSITIONS AND METHODS FOR IN VIVO POST TRANSLATIONAL MODIFICATION The Wistar Institute POPA, ILEANA 1633 §112 Non-Final OA 17d overdue Pending Dec 09, 2020
17111158 DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES The United States Government AS Represented By The Department Of Veterans Af PERREIRA, MELISSA JEAN 1618 Other Non-Final OA 50d Pending Dec 03, 2020
16755198 A Cell-Based Seeding Assay for Huntingtin Aggregation The Regents of the University of California BALLARD, KIMBERLY 1675 §103 Final Rejection 20d Pending Apr 10, 2020
16347861 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE The Wistar Institute ZEMAN, ROBERT A 1645 §112 Final Rejection 10d overdue Pending May 07, 2019
15548197 INTEGRATED PAINLESS BONE MARROW BIOPSY DEVICE Yale University CATINA, MICHAEL ANTHONY 3791 §103 Final Rejection 30d Pending Aug 02, 2017

Managing Riverside Law LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month